scholarly article | Q13442814 |
P50 | author | Ellen Schlichting | Q27049894 |
Riyas Vettukattil | Q42726521 | ||
Tone F. Bathen | Q61104171 | ||
Steinar Lundgren | Q65706815 | ||
Guro F. Giskeødegård | Q65706869 | ||
Hans E Fjøsne | Q114422032 | ||
P2093 | author name string | Hartmut Schäfer | |
Inger Thune | |||
Hanne Frydenberg | |||
Vidar G Flote | |||
Gro F Bertheussen | |||
Jon Lømo | |||
Erik Wist | |||
Torfinn S Madssen | |||
P2860 | cites work | 2-Aminoadipic acid is a biomarker for diabetes risk | Q24617890 |
Understanding the role of the kynurenine pathway in human breast cancer immunobiology | Q26773472 | ||
Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis | Q26858839 | ||
Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes | Q42834541 | ||
Metabolic profile, physical activity, and mortality in breast cancer patients | Q43250781 | ||
Serum molecular signatures of weight change during early breast cancer chemotherapy. | Q43253835 | ||
Association between weight gain during adjuvant chemotherapy for early-stage breast cancer and survival outcomes | Q43746121 | ||
Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia | Q44434565 | ||
Taxane-Induced Peripheral Neurotoxicity. | Q45759415 | ||
Feasibility of using an oleate-rich diet to reduce the susceptibility of low-density lipoprotein to oxidative modification in humans | Q46184312 | ||
Association between changes in body fat and disease progression after breast cancer surgery is moderated by menopausal status | Q47102767 | ||
In Vitro lipolysis is associated with whole-body lipid oxidation and weight gain in humans | Q47256580 | ||
The Effects of Resistance Exercise on Biomarkers of Breast Cancer Prognosis: A Pooled Analysis of Three Randomized Trials | Q47399081 | ||
Kynurenines: Tryptophan's metabolites in exercise, inflammation, and mental health | Q47659177 | ||
Tryptophan circuit in fatigue: From blood to brain and cognition | Q47687012 | ||
Asymmetric dimethylarginine predicts clinical outcomes in ischemic chronic heart failure | Q48324317 | ||
Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association. | Q50045986 | ||
Systemic inflammation is linked to low arginine and high ADMA plasma levels resulting in an unfavourable NOS substrate-to-inhibitor ratio: the Hoorn Study. | Q51506465 | ||
Beneficial effects of phosphatidylcholine on high-fat diet-induced obesity, hyperlipidemia and fatty liver in mice. | Q53248526 | ||
Changes in serum lipids and lipoproteins in cancer patients during chemotherapy | Q68018409 | ||
Effects of oxidative stress on glycerolipid acyl turnover in rat hepatocytes | Q73724857 | ||
Asymmetric dimethylarginine and carotid atherosclerosis in Type 2 diabetes mellitus | Q85388854 | ||
NMR-based metabolomics of biofluids in cancer | Q88409664 | ||
Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signals | Q28295232 | ||
Metabolomic profiling reveals mitochondrial-derived lipid biomarkers that drive obesity-associated inflammation | Q28728589 | ||
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials | Q29547513 | ||
Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects--a monozygotic twin study | Q30829796 | ||
Multilevel data analysis of a crossover designed human nutritional intervention study | Q33364501 | ||
Multivariate paired data analysis: multilevel PLSDA versus OPLSDA. | Q33546330 | ||
Weight change during chemotherapy in breast cancer patients: a meta-analysis | Q33556428 | ||
Insulin resistance is associated with higher intramyocellular triglycerides in type I but not type II myocytes concomitant with higher ceramide content | Q33556682 | ||
Molecular enzymology of carnitine transfer and transport | Q33938860 | ||
The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease | Q33940891 | ||
Side effects of adjuvant treatment of breast cancer | Q34295656 | ||
Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes. | Q34358476 | ||
Oxidative stress and apoptosis: impact on cancer therapy. | Q34642005 | ||
Plasma lipid profiling shows similar associations with prediabetes and type 2 diabetes | Q35004985 | ||
Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host | Q35753611 | ||
Chemotherapy Agents Alter Plasma Lipids in Breast Cancer Patients and Show Differential Effects on Lipid Metabolism Genes in Liver Cells | Q35903199 | ||
Specific Metabolic Markers Are Associated with Future Waist-Gaining Phenotype in Women | Q36056872 | ||
Cardiovascular Disease Mortality Among Breast Cancer Survivors | Q36338451 | ||
Lipoprotein subfractions by nuclear magnetic resonance are associated with tumor characteristics in breast cancer | Q36680439 | ||
Elevated asymmetric dimethylarginine in young adult survivors of childhood acute lymphoblastic leukemia: a preliminary report | Q37261768 | ||
Asymmetric dimethylarginine attenuates serum starvation-induced apoptosis via suppression of the Fas (APO-1/CD95)/JNK (SAPK) pathway. | Q37299599 | ||
Defective adipose lipolysis and altered global energy metabolism in mice with adipose overexpression of the lipolytic inhibitor G0/G1 switch gene 2 (G0S2). | Q37511665 | ||
Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity. | Q37699221 | ||
Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study | Q37723285 | ||
A plasma metabolomic signature discloses human breast cancer. | Q37746050 | ||
Sphingolipid metabolism and analysis in metabolic disease | Q37930541 | ||
Importance of metabolic changes induced by chemotherapy on prognosis of early-stage breast cancer patients: a review of potential mechanisms | Q37963505 | ||
Ceramide-orchestrated signalling in cancer cells. | Q38067062 | ||
Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention. | Q38649483 | ||
Long-Term Cardiovascular Risk After Radiotherapy in Women With Breast Cancer | Q39321063 | ||
Taxane-based adjuvant chemotherapy reduces endothelin-1 and symmetric dimethylarginine levels in patients with breast cancer | Q39828355 | ||
Obesity, adipokines, and C-peptide are associated with distinct plasma phospholipid profiles in adult males, an untargeted lipidomic approach. | Q40109903 | ||
Inflammation-sensitive plasma proteins are associated with future weight gain | Q40572272 | ||
Stimulation by de novo-synthesized ceramide of phospholipase A(2)-dependent cholesterol esterification promoted by the uptake of oxidized low-density lipoprotein in macrophages. | Q40731446 | ||
Pretreatment Insulin Levels as a Prognostic Factor for Breast Cancer Progression | Q41045365 | ||
Does the 1H-NMR plasma metabolome reflect the host-tumor interactions in human breast cancer? | Q41472829 | ||
An observational study to examine changes in metabolic syndrome components in patients with breast cancer receiving neoadjuvant or adjuvant chemotherapy | Q41492616 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | lipoprotein | Q28350 |
weight gain | Q3403879 | ||
P304 | page(s) | 1144-1154 | |
P577 | publication date | 2018-10-01 | |
P1433 | published in | British Journal of Cancer | Q326309 |
P1476 | title | Metabolite and lipoprotein responses and prediction of weight gain during breast cancer treatment | |
P478 | volume | 119 |